Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC

BACKGROUND: Patients with human papillomavirus (HPV+) head and neck squamous cell carcinoma (HNSCC) have superior prognoses compared with patients with HPV− HNSCC and strategies for treatment de-escalation are under investigation for the HPV+ setting. However, the survival advantage associated with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunother Cancer
Main Authors: Gui, Shanying, O'Neill, W Quinn, Teknos, Theodoros N, Pan, Quintin
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2021
Teme:
Immunotherapy Biomarkers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978288/
https://ncbi.nlm.nih.gov/pubmed/33737336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001259
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki